Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
A Handbook for Diagnosis and Management
Buch in deiner Nähe kaufen
Beschreibung
With the increasing use of immune checkpoint inhibitors (ICI) across various cancers, the trends for indication at earlier stages, and the use of combination immunotherapy, the frequency of ICI-induced immune-related adverse events (irAE) is expected to grow substantially. Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk-benefit ratios with respect to the primary cancer. Several rheumatic irAE have been reported with ICI therapy including arthritis, myositis, polymyalgia-like syndromes, sicca/Sjogren-like manifestations, and several other less common systemic autoimmune features commonly associated with connective tissue disease.
Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy is an essential resource for physicians and related professionals, residents, fellows, graduate students and nurses alike in rheumatology, clinical immunology, oncology, and internal medicine.
With the increasing use of immune checkpoint inhibitors (ICI) across various cancers, the trends for indication at earlier stages, and the use of combination immunotherapy, the frequency of ICI-induced immune-related adverse events (irAE) is expected to grow substantially. Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk-benefit ratios with respect to the primary cancer. Several rheumatic irAE have been reported with ICI therapy including arthritis, myositis, polymyalgia-like syndromes, sicca/Sjogren-like manifestations, and several other less common systemic autoimmune features commonly associated with connective tissue disease.
Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy is an essential resource for physicians and related professionals, residents, fellows, graduate students and nurses alike in rheumatology, clinical immunology, oncology, and internal medicine.
Written in a handbook format with clinical tips for a variety of medical professionals Discusses epidemiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of rheumatic irAE Includes management algorithms for arthritis, myositis, polymyalgia rheumatica, and Sjogren’s syndrome Addresses cancer immunotherapy in patients with preexisting rheumatic diseases
Autor*in
Maria E. Suarez-Almazor
Themen in »Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy«
Cancer immunotherapy and rheumatic diseases Cancer immunotherapy and arthritis Cancer immunotherapy and myositis Cancer immunotherapy and polymyalgia rheumatic Cancer immunotherapy and Sjogren’s syndrome Cancer immunotherapy-induced rheumatic diseases Immune checkpoint inhibitors (ICI) Rheumatic immune-related adverse events (irAE)